期刊文献+

共振瑞利散射光谱法测定药物中利福平——基于甲基紫的络合反应

Resonance Rayleigh Scattering Spectrometric Determination of Rifampicin——Based on Its Complex Reaction with Methyl Violet
下载PDF
导出
摘要 在pH9.73的Tris-盐酸缓冲介质中,一定量的利福平与1.0×101mol·L^-1甲基紫溶液2.5mL反应生成的络合物,产生共振瑞利散射光谱,在其最大共振光散射峰波长381nm处测定共振瑞利散射的强度JRRS。利福平的质量浓度在0.823mg·L^-1以内与样品及空白溶液的散射强度值之差(ΔIRRS)呈线性关系,方法的检出限(3s/k)为0.0039mg·L^-1。方法用于药物中利福平含量的测定,测定结果与药典法测得结果相符,回收率在99.0%~102%之间,测定值的相对标准偏差(n=6)在0.8oA~1.1%之间。 In a Tris-HCl buffer medium of pH 9.73, an appropriate amount of rifampicin was reacted with 2.5 mL of 1. 0 × 10^-3 mol · L^-1 methyl violet solution, to form a complex and producing resonance Rayleigh Scattering (RRS), the intensity (IRRs) of which was measured at the wavelength of scattering peak (381 nm). Values of ΔIRRS [ IRRS (sample)- IRRS (blank)] was found to keep lenear relationship with values of mass concentration of rifampicin in the range within 0. 823 mg · L^-1 , with limit of detection (3s/k) of 0. 003 9 mg · L^-1. The proposed method was applied to the determination of rifampicin in its drug samples, giving results checked quite well with the results found by the method of pharmacopeia. Values of recovery and RSD's (n=6) found were in the ranges of 99.0%-102% and 0.8%-1.1% respectively.
出处 《理化检验(化学分册)》 CAS CSCD 北大核心 2013年第12期1465-1467,共3页 Physical Testing and Chemical Analysis(Part B:Chemical Analysis)
基金 重庆市教委科技基金资助项目(KJ121321)
关键词 共振瑞利散射光谱法 利福平 甲基紫 Resonance rayleigh scattering spectrometry Rifampicin Methyl violet
  • 相关文献

参考文献7

二级参考文献57

  • 1谭奥,苏茵.利福平滴眼液含量测定方法的改进[J].中国抗生素杂志,2005,30(3):174-175. 被引量:1
  • 2回瑞华,侯冬岩.三波长-光谱法测定利福平的含量[J].光谱学与光谱分析,1995,15(5):95-98. 被引量:19
  • 3Hilman A G, Rail T, Nier A, Taylor P. The Pharmacological Basis of Therapeutics. New York: McGraw-Hill, 1996.
  • 4Vichez J L, Ballesteros O, Taoufiki J, Sanchez-Palencia G, Navalon A. Determiantion of the antibacterial norfloxacin in human urine and serum samples by solid-phase spectrofluorimetry. Anal Chim Acta, 2001, 444(2): 179-286.
  • 5EI-Walily A F, Razak O A, Belal A F, Bakry R S. Determination of norfloxacin spectrophotometrically using 2,4-dinitrofluorobenzen.j Pharm Biomed Anal, 1999, 21(5): 1069-1076.
  • 6Ni Y N, Wang Y, Kokot S. Multicomponent kinetic spectrophotometric determination of pefloxacin and norfloxacin in pharmaceutical preparations and human plasma samples with the aid of chemometrics. Spectrochim Acta Part A, in press.
  • 7Nageswara R R, Nagaraju V. Separation and determination of synthetic impurities of norfloxacin by reversed-phase high performance liquid chromatography. J Pharm Biomed Anal, 2004, 34(5): 1049-1056.
  • 8Liorent-Martinez E J, Dela-Peria M, Gomez F, Salinas F. Teribium-sensitized luminescence optosensor for the determination of norfloxacin in biological fluids. Anal Chim Acta, 2005, 532(2): 159-164.
  • 9Sadeghi S, Karimi E. Spectrophotometric determination of rifampcin through chelate formation and charge transfer complexation in pharmaceutical preparation and biological fluids. Chem Pharm Bull, 2006, 54(8): 1107-1112.
  • 10Calleja I, Blanco-Prieto M J, Ruz N, Renedo M J, Dios-Vieitez M C. High-performance liquid-chromatographic determination of rifampicin in plasma and tissues. J Chromatogr, 2004, 1031 (1-2): 289-294.

共引文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部